July 12 2006; 7:30 am-5:30 pm — Bethesda MD
http://sacserv.com/tracking.jsp?linkid=33881&subid=3838834&campid=148303&type=0

May 16, 2006 — MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM) — COSTA MESA CA USA — The US FDA announced today its FDA Workshop on Testing for Malarial Infections in Blood Donors, scheduled for July 12 2006 in Bethesda MD.

FOCUS:

The goal of the workshop is to gather and review current information on scientific developments that might support donor testing for malarial infections as a part of pre-donation screening, or, alternatively, follow-up testing of deferred at-malaria-risk donors to permit a reduced deferral period.

The workshop will feature presentations by national and international experts from government, academic institutions and industry.

TOPICS:

Topics to be covered include the impact of transfusion-transmitted malaria on the US blood supply, current donor deferral policies practiced in the US and Europe, available and emerging technologies that could be used to test blood donors for malarial infections, and potential effects of donor testing for malarial infections on the safety and availability of the blood supply.

LOCATION:

National Institutes of Health
Natcher Conference Center
45 Center Dr Rm E1/E2
Bethesda MD 20892

REGISTRATION:

There is no registration fee for this meeting. Early registration is recommended before June 23 2006, as seating is limited to 150. Onsite registration will be limited to space available on the day of the workshop beginning at 7:15 am.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Rhonda Dawson
Program Coordinator
FDA Office of Blood Research & Review
Center for Biologics Evaluation & Research
1401 Rockville Pike, HFM-302
Rockville MD 20852
301-827-6129 phone
301-827-2843 fax
[email protected]